Nuclear Imaging Market Size, Analysis, Share & Forecast 2031
Nuclear Imaging Market Size, Analysis, Share & Forecast 2031
Segments - Nuclear Imaging Market by Products (Radioisotope [Diagnostic Technology {PET Radioisotopes (Rubidium-82, Fluorine-18, and Others) & SPECT Radioisotopes (Iodine, Gallium, Technetium-99m, Thallium-201, and Others)} & Equipment]), Applications (PET Applications [Neurology, Oncology, Cardiology, and Others] & SPECT Applications [Thyroid, Cardiology, Neurology, and Others]), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa)– Global Industry Analysis, Growth, Shares, Size, Trends, and Forecast 2021-2028
Upcoming
| Report ID :HC-1368
| 4.1 Rating
| 73 Reviews
| 214 Pages
| Format :
Report Description
The nuclear imaging market size is anticipated to expand at a significant CAGR during the forecast period 2021–2028. Growth of the market is attributed to increasing initiatives by government, changing customers’ preference, and rising prevalence of cancer.
Nuclear imaging is a system of generating images from various parts of the human body by identifying radiation, after a radioactive tracer is given to the customers. The nuclear images are digitally obtained on a computer and transferred to a nuclear medicine physician. Radioactive tracers utilized in nuclear imaging are inserted into the human body. In some cases, they are given through mouth.
The Covid-19 pandemic affected the demand and supply of nuclear imaging market. Lockdown across the globe, supply chain disorders, and oscillating supply of raw materials forced manufacturers to shut down production leading to unfortunate decline in market growth. Launch of vaccines to combat the Covid-19 pandemic is expected to contribute to the market growth over the forecast period.
Market Trends, Drivers, Restraints, and Opportunities
- Technological advancement in nuclear imaging sector is projected to boost the market.
- Increasing diagnostic applications in various diseases is the major factor fueling the market.
- Lack of awareness about the nuclear imaging is projected to restrict the market expansion during the forecast period.
- High price of nuclear imaging is anticipated to hamper the market growth in the coming years.
- R&D investment and technological advancement in nuclear imaging market is projected to offer lucrative opportunities for the market players.
Scope of the Nuclear Imaging Market Report
The report on the Asia Pacific completion equipment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Nuclear Imaging Market –Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018-2019 |
|
Forecast Period |
2021-2028 |
|
Segmentation |
Products (Radioisotope [Diagnostic Technology {PET Radioisotopes (Rubidium-82, Fluorine-18, and Others) & SPECT Radioisotopes (Iodine, Gallium, Technetium-99m, Thallium-201, and Others)} & Equipment]), Applications (PET Applications [Neurology, Oncology, Cardiology, and Others] & SPECT Applications [Thyroid, Cardiology, Neurology, and Others]) |
|
Geographical Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
|
Key Players covered in the Report |
Canan Medical Systems Corporation; Nordion (Canada Inc.); CMR NAVISCAN (GAMMA MEDICA INC.); Siemens Healthineers; GE Healthcare; Bracco Imaging SpA; Koninklijke Philips NV; Curium; NTP Radioisotopes SOC; and Cardinal Health Inc. |
Nuclear Imaging Market Segment Insights
The PET applications segment accounts for a key share of the market
Based on applications, the nuclear imaging market is bifurcated into PET applications & SPECT applications. The PET application segment is sub-segmented into neurology, oncology, cardiology, and others. The SPECT applications segment is sub-segmented into thyroid, cardiology, neurology, and others. The PET applications segment accounts for a key share of the market.
Growth of the market is attributed to introduction of sophisticated software and introduction of new radiopharmaceuticals for diagnosis. However, the SPECT applications segment is anticipated to expand at a rapid pace during the forecast period due to factors such as rapid development in molecular imaging and increasing awareness among people.
The SPECT radioisotopes segment accounts for a significant share of the market
Based on products, the market is segregated into radioisotope & equipment. The radioisotope segment is sub-segmented into diagnostic technology. The diagnostic technology is further sub-segmented into PET radioisotopes & SPECT radioisotopes. The PET radioisotopes segment is sub-segmented into rubidium-82, fluorine-18, and others. The SPECT radioisotopes segment is sub-segmented into iodine, gallium, technetium-99m, thallium-201, and others. The SPECT radioisotopes segment accounts for a significant share of the market.
Growth of the market is attributed to increased prescription by physicians and increasing focus on personalized medicines. The PET radioisotopes are anticipated to expand at a rapid pace during the forecast period due to factors such as rising investment by private & public sectors and rising technological advancement in radio-trace field.
North America is anticipated to hold major market share
On the basis of region, the nuclear imaging market is categorized as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of Asia Pacific is estimated to expand at a high CAGR during the forecast period due to increasing convenient & efficient technologies and rising requirement for skilled professions. The market of North America is estimated to hold major market share due to rising demand for data integrated imaging systems and increasing aging population.
Segments
The nuclear imaging market has been segmented on the basis of
Products
- Radioisotopes
- Diagnostic Technology
- PET Radioisotopes
- Rubidium-82
- Flucorine-18
- Others
- SPECT Radioisotopes
- Iodine
- Gallium
- Technetium-99m
- Thallium-201
- Others
- PET Radioisotopes
- Diagnostic Technology
- Equipment
Applications
- PET Applications
- Neurology
- Oncology
- Cardiology
- Others
- SPECT Applications
- Thyroid
- Cardiology
- Neurology
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Canan Medical Systems Corporation
- Nordion (Canada) Inc.
- CMR NAVISCAN (GAMMA MEDICA INC.)
- Siemens Healthineers
- GE Healthcare
- Bracco Imaging SpA
- Koninklijke Philips NV
- Curium
- NTP Radioisotopes SOC
- Cardinal Health Inc.
Competitive Landscape
Key players competing in the nuclear imaging market include Canan Medical Systems Corporation; Nordion (Canada Inc.); CMR NAVISCAN (GAMMA MEDICA INC.); Siemens Healthineers; GE Healthcare; Bracco Imaging SpA; Koninklijke Philips NV; Curium; NTP Radioisotopes SOC; and Cardinal Health Inc.
Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and rise their production line of the business in the coming years.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Imaging Market Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nuclear Imaging Market Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nuclear Imaging Market Market - Supply Chain
4.5. Global Nuclear Imaging Market Market Forecast
4.5.1. Nuclear Imaging Market Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nuclear Imaging Market Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Nuclear Imaging Market Market Absolute $ Opportunity
5. Global Nuclear Imaging Market Market Analysis and Forecast by Region
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Region
5.2.2. Y-o-Y Growth Projections by Region
5.3. Nuclear Imaging Market Market Size and Volume Forecast by Region
5.3.1. North America
5.3.2. Latin America
5.3.3. Europe
5.3.4. Asia Pacific
5.3.5. Middle East and Africa (MEA)
5.4. Absolute $ Opportunity Assessment by Region
5.5. Market Attractiveness/Growth Potential Analysis by Region
5.6. Global Nuclear Imaging Market Demand Share Forecast, 2019-2026
6. North America Nuclear Imaging Market Market Analysis and Forecast
6.1. Introduction
6.1.1. Basis Point Share (BPS) Analysis by Country
6.1.2. Y-o-Y Growth Projections by Country
6.2. North America Nuclear Imaging Market Market Size and Volume Forecast by Country
6.2.1. U.S.
6.2.2. Canada
6.3. Absolute $ Opportunity Assessment by Country
6.4. Market Attractiveness/Growth Potential Analysis
6.4.1. By Country
6.4.2. By Product Type
6.4.3. By Application
6.5. North America Nuclear Imaging Market Demand Share Forecast, 2019-2026
7. Latin America Nuclear Imaging Market Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.1.3. Latin America Average Pricing Analysis
7.2. Latin America Nuclear Imaging Market Market Size and Volume Forecast by Country
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Rest of Latin America
7.3. Absolute $ Opportunity Assessment by Country
7.4. Market Attractiveness/Growth Potential Analysis
7.4.1. By Country
7.4.2. By Product Type
7.4.3. By Application
7.5. Latin America Nuclear Imaging Market Demand Share Forecast, 2019-2026
8. Europe Nuclear Imaging Market Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Europe Average Pricing Analysis
8.2. Europe Nuclear Imaging Market Market Size and Volume Forecast by Country
8.2.1. Germany
8.2.2. France
8.2.3. Italy
8.2.4. U.K.
8.2.5. Spain
8.2.6. Russia
8.2.7. Rest of Europe
8.3. Absolute $ Opportunity Assessment by Country
8.4. Market Attractiveness/Growth Potential Analysis
8.4.1. By Country
8.4.2. By Product Type
8.4.3. By Application
8.5. Europe Nuclear Imaging Market Demand Share Forecast, 2019-2026
9. Asia Pacific Nuclear Imaging Market Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Asia Pacific Average Pricing Analysis
9.2. Asia Pacific Nuclear Imaging Market Market Size and Volume Forecast by Country
9.2.1. China
9.2.2. Japan
9.2.3. South Korea
9.2.4. India
9.2.5. Australia
9.2.6. Rest of Asia Pacific (APAC)
9.3. Absolute $ Opportunity Assessment by Country
9.4. Market Attractiveness/Growth Potential Analysis
9.4.1. By Country
9.4.2. By Product Type
9.4.3. By Application
9.5. Asia Pacific Nuclear Imaging Market Demand Share Forecast, 2019-2026
10. Middle East & Africa Nuclear Imaging Market Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Middle East & Africa Average Pricing Analysis
10.2. Middle East & Africa Nuclear Imaging Market Market Size and Volume Forecast by Country
10.2.1. Saudi Arabia
10.2.2. South Africa
10.2.3. UAE
10.2.4. Rest of Middle East & Africa (MEA)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Market Attractiveness/Growth Potential Analysis
10.4.1. By Country
10.4.2. By Product Type
10.4.3. By Application
10.5. Middle East & Africa Nuclear Imaging Market Demand Share Forecast, 2019-2026
11. Competition Landscape
11.1. Global Nuclear Imaging Market Market: Market Share Analysis
11.2. Nuclear Imaging Market Distributors and Customers
11.3. Nuclear Imaging Market Market: Competitive Dashboard
11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
11.4.1. Canan Medical Systems Corporation
11.4.2. Nordion (Canada) Inc.
11.4.3. CMR NAVISCAN (GAMMA MEDICA INC.)
11.4.4. Siemens Healthineers
11.4.5. GE Healthcare
11.4.6. Bracco Imaging SpA
Methodology
Related Reports
Some other reports from this category!
Our Clients
